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https://doi.org/10.1016/j.patter.2020.100129THE BIGGER PICTURE External validation is critical for establishing machine learning model quality. To
improve rigor and introduce structure into external validation processes, we propose two extensions,
convergent and divergent validation. Using a case study, we demonstrate how convergent and divergent val-
idations are set up and also discuss technical considerations for gauging performance, including establish-
ment of statistical rigor, how to acquire valid external data, determining the number of times an external vali-
dation needs to be performed, and what to do when multiple external validations disagree with each other.
Finally, we highlight that external validation remains andwill be highly relevant, even to newmachine learning
paradigms.
Development/Pre-production: Data science output has been
rolled out/validated across multiple domains/problemsSUMMARY
We discuss the validation of machine learning models, which is standard practice in determining model ef-
ficacy and generalizability. We argue that internal validation approaches, such as cross-validation and boot-
strap, cannot guarantee the quality of a machine learning model due to potentially biased training data and
the complexity of the validation procedure itself. For better evaluating the generalization ability of a learned
model, we suggest leveraging on external data sources from elsewhere as validation datasets, namely
external validation. Due to the lack of research attractions on external validation, especially a well-structured
and comprehensive study, we discuss the necessity for external validation and propose two extensions of
the external validation approach that may help reveal the true domain-relevant model from a candidate
set. Moreover, we also suggest a procedure to check whether a set of validation datasets is valid and intro-
duce statistical reference points for detecting external data problems.INTRODUCTION
Machine learning is among themost powerful tools for knowledge
discovery from data today. If a learned model (trained classifier)
correctly captures domain-relevant features (i.e., factors that are
explanatory and causal), the model is deemed domain relevant
and more likely explainable (i.e., the set of interpretable decision
rules is logical and lends itself toward abetter domain understand-
ing.) Such models may be more confidently used in a wide variety
of practical applications, e.g., predicting credit risk,1 recidivism,2
and the state of charge and health of batteries.3
As therearemanydifferentpurposesandapplications inmachine
learning, in thispaper,we limitourselves tobinarypredictivemodels
for about any outcome, with focus on a high-dimensional featureThis is an open access article under the CC BY-Nspace (i.e., a very large amount of potential predictors). We are
also concerned with a statistical feature selection paradigm on
the discussions of different issues as well as explanation of ap-
proaches. For such settings, model validation is critical for discov-
ering domain-relevantmodelswith better generalization ability, and
further implies better interpretability. This is a very specialized
context. For general machine learning researches that may incur
more modalities (e.g., visions and robotics) where we may
encounter many black box models, it is not a trivial case to imply
interpretability only from validation performance. There is still a
gap to go from those machine learning problems with many black
box models. We do not consider these types of problems here.
Learnedmodels are evaluated through theprocess of validation,
which is defined as the process of evaluating accuracy—andmorePATTER 1, November 13, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Validation Methods Broadly Fall
into Two Types: Internal and External
Internal validation (IV) involves first splitting the input
data into a training set and a test set. The training set
is used to train themodel while the test set is used to
check the accuracy of the model after it has been
trained. External validation (EV) uses the entire input
data for model training and the validation of the
model is done using an independently derived da-
taset(s).
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commonly used than accuracy in the machine learning litera-
ture—ondata thatarenotpartof the trainingset.Broadly, validation
is categorizable into "internal" and "external" (Figure 1). Internal
validation (IV) approaches are economical, as they involve splitting
one input dataset into parts—with some parts used for training the
classifier (training data), and the remainder used for validation (test
data). This process is repeated until each part has been used at
least once as testing data. This process is also commonly referred
to as cross-validation. While considered industry standard and
very commonly used, IV procedures are highly heterogeneous
and tuneable.4 In particular, it is left to the discretion of the analyst
which procedural subtype (e.g., k-fold, bootstrap) to use and what
theparametersare (e.g., valueof k,numberof bootstrap iterations).
Another issue is that, if the original input data are, e.g., a biased
sample, cross-validation becomes a biased evaluation of a bias-
edly trained model on a test set that is biased in the same way.
External validation (EV) involves the use of independently
derived datasets (hence, external), to validate the performance
of a model that was trained on initial input data. EV is sometimes
referred to as independent validation—we find this a misnomer,
as the independently derived (by virtue of being sourced from
elsewhere) external dataset may not be truly independent of
the training data.5 Independent validation is also sometimes
used to refer to a validation study by other researchers than
the researchers who developed the model.
EV is usually considered important evidence for generalizability.
Due to the validation set coming from an independent source, any
featureset thatwas falsely selecteddue to idiosyncrasiesof the input
trainingdata (e.g., technical or samplingbias)would likely fail.Hence,
apositiveperformance inEV is regardedasaproofofgeneralizability.
GOOD PREDICTION ACCURACY OFTEN DOES NOT
IMPLY DOMAIN RELEVANCE
Capturing domain-relevant features for model inclusion is impor-
tant as these lead toward reasonable explanations for the ma-
chine learning model. To avoid overfitting or non-generalizability
issues, we should strive toward models that use true causal pre-
dictors of the outcome. In a health-related example, cancer
genes affect many other gene groups, particularly, growth2 PATTER 1, November 13, 2020genes.6 A model built on growth genes,
while able to differentiate normal tissues
from cancer tissues, may also misdiag-
nose a tissue of rapidly growing cells as
cancer.
While domain-relevant features are use-
ful for explaining why amodel works well, itis not straightforward to mine these frommodels. Before we can
perform causal interpretation of predictive analytics, the model
first needs to give accurate predictions of the outcome. Howev-
er, it appears that obtaining accurate prediction is fairly easy,
evenwith common validation approaches, such as the bootstrap
and cross-validation. However, an accurate model can be
naively overfitted: for example, in a medical imaging study,
Zech and colleagues7 noticed only after training their neural
network that it heavily relied on the word ‘‘portable’’ within an
X-ray image, representing the type of X-ray equipment rather
than the medical content of the image.
Meaningful and clean data, in the sense that the captured
features are informative and that the data are devoid of noise
or confounding effects, may yield accurate models. Unfortu-
nately, in practice, any collected data are effectively a sample,
and may not be a true representation of the population under
study. Before training the model, it is often good to check for
sample bias, and where possible check for errors stemming
from sample size,8,9 heterogeneity,10 noise,11 and confounding
factors.12
Because we cannot rule out that any input data are error-free
and unbiased, a good accuracy within a cross-validation is
generally insufficient to ascertain whether a model is domain
relevant and generalizable. Therefore, it is good practice to
repeatedly challenge the learned model with independently
sampled data (EV). If the good performance persistently repli-
cates, the more likely the learned model is generalizable.
WHY EV SHOULD BE PERFORMED MORE OFTEN?
Statistical techniques can be used to reason about data domain
representativeness and domain relevance, thereby providing a
proxy on model interpretability.12,13 But these techniques may
not be easy to deploy or may require correct prior knowledge
that may not exist.
Since training data may not be truly representative and may
not be properly prepared, we should regard any trained model,
despite having passed IV (e.g., via cross-validation), as poten-
tially non-generalizable. Before actual deployment into the real
world setting, we recommend evaluating a learned model via
EV. This is a simple process that involves challenging the model
ll
OPEN ACCESSPerspectivewith additional data that are not involved in the original input data
or aremeaningfully different (for example, in the imaging problem
of Zech et al.7 they could have tested for overfitting by using an
EV in which the input set was produced using different X-ray
equipment).
The logic behind EV is sound: data taken fromcompletely sepa-
rate sources have less in common, but nonetheless may capture
useful domain-relevant aspects. A well-trained model that cap-
tures informative features is robust and will continue to exhibit
good results even when repeatedly challenged with new data.
EV thus provides an assurance that models passing this step
are more likely domain-interpretable. There are nonetheless
some caveats, as discussed in the remainder of this article.
THE CASE STUDY SETUP IN SUPPORT OF THE EV
As there are many different purposes and applications in ma-
chine learning, in this paper, we limit ourselves to binary predic-
tive models for any outcome, with a focus on a high-dimensional
feature space (i.e., a very large amount of potential predictors).
We are concerned with a statistical feature selection paradigm
on the discussions of different issues as well as explanation of
approaches. For such settings, model validation is critical for
discovering domain-relevant models with better generalization
ability, which further implies better interpretability. This is a
very specialized context. We illustrate our point using gene
signature selection in breast cancer.6,14 A gene signature can
be thought of as a set of features where each feature is the
expression level of a gene; and the set forms a prediction model,
which is a classifier in the context of our discussion here.
We first encountered issues with EV in the Venet et al.15 study
of breast cancer prognostic signatures, and explored the impli-
cations for machine learning.6,12,14,16 In the Venet et al. study,
they evaluated multiple reported gene signatures against a sin-
gle large dataset, and found that none of these gene signatures
could beat randomly generated gene signatures or domain-irrel-
evant signatures. In other words, each reported breast cancer
signature, as a consequence of intensive study, gives rise to a
highly accurate model. But an accurate model may not be
domain relevant, as the selected features may in themselves
be non-causal correlates. This leads to many pretender models
(high performance on a dataset, but no relevance).
We propose that a simple way of rooting out pretender models
is to evaluate the substitutability of the feature set; i.e., gener-
ating randomized feature sets to create null models against
which you evaluate your actual model. This may take the
following form. Suppose you are developing a model for predict-
ing two classes, A versus B, on a moderately large feature space
of 20,000 measured features. Since there are many features,
dimensionality reduction is often necessary, and so, from the
initial 20,000 feature space, you pick 10 based on class correla-
tion (or any other feature selection approach17), and use these 10
features to train a model X using input training data D1. Model X,
when validated on validation data D2, produces an accuracy of
90%, which appears reasonable. This suggests that model X is
generalizable, and therefore is domain relevant. However, a
randomly selected feature set, also of size 10, is also used to
train a model XR on D1, producing an accuracy of 90% on D2.
Repeating this experiment many times over shows that theaverage prediction accuracy of random feature sets is about
92%. The accuracy based on X is scarcely better than the accu-
racy of XR. In a typical setting, people would not perform this
randomization test, and merely report X as good based on the
EV prediction accuracy of 90%. While certainly a good result,
X has, in fact, little to no information value since random features
sets do as well, if not better.
While this technique does not leverage on domain knowledge
or carefully constructed explainable models, it can be used
straightforwardly for eliminating falsely high-performing
models.4 This example also tells us that we cannot trust the ac-
curacy of a single EV as objective evidence of domain relevance.
In a robust model validation strategy, IV and EV should be
used together in a tandem configuration where IV is first de-
ployed to provide a quick sense of performance before relying
on EV to determine domain-correctness. In particular, IV is un-
likely to be able to detect if the training dataset is not domain
representative; and non-domain representativeness of training
data is not an uncommon situation (cf. https://channels.
theinnovationenterprise.com/articles/bad-data-is-ruining-machine-
learning-here-s-how-to-fix-it). EV is an essential procedure in
counteracting this. Moreover, EV provides robustness to class-
prediction accuracy, which in turn acts as a proxy for interpret-
ability. Unfortunately, while it is common to encounter literature
covering tutorials and explanations on how to design and
execute IV,18–20 with accompanying studies of its theoretical
and statistical properties,21 information on how to conduct EV
properly or evaluating the outcome of an EV (when you should
or should not believe the results of an EV) is less common. In
an advanced search on Nature Publishing Group’s website
where we searched for publications containing the terms =
‘‘cross-validation classifier’’ and publication date = ‘‘2019 to
2020,’’ we then looked at the first 40 results, after discarding a
tutorial and a review article. Of these 40 results, 20 seemed
questionable (i.e., there was no evaluation based on clear inde-
pendent dataset) and 20 seemed appropriate (i.e., had indepen-
dent datasets or it was not clear that they had an independent
dataset). So, one might say that there is some evidence that pa-
pers that use cross-validation as part of their study methodology
have a tendency (50%) to not use an independent validation
dataset. The search above returned 1,296 results. After dropping
‘‘cross-validation’’ from the search terms, 2,566 results were re-
turned. So, about half (1,296/2,566) of the papers published by
the Nature Group in 2019–2020 that pertain to constructing clas-
sifiers (mostly for biomedical applications), rely on cross-valida-
tion as part of their methodology. Of these, about half can be
considered questionable, as their constructed classifiers were
not evaluated on independent datasets. In other words, about
25% (50% * 50%) of the articles published from 2019 to 2020
by Nature Group pertaining to developing classifiers lack suffi-
cient validation.
EV is not as trivial as simply finding some new data to chal-
lenge the model. That would assume that any data, as long as
sourced elsewhere, would do. Clearly, such looseness lacks
rigor. There is also the need for correct interpretive logic to be
used alongside evaluation of an EV. For example, when the EV
is conducted improperly such that low accuracy is observed,
we may mistakenly think the input data were uninformative or
that the model was overfitted to the training data. When an EVPATTER 1, November 13, 2020 3


































































OPEN ACCESS Perspectivemistakenly informs that a correctly trained model failed to gener-
alize, it is a waste (or a form of false negative, if you like).
Conversely, we should be just as wary when a persistently
good EV result is observed, as it may be due to data biases
(e.g., the presence of a batch effect),22 false statistical assump-
tions (the used case requirements of the statistical model are not
met),13 or theremay be an incompatibility between the input data
and the real world (e.g., random sampling biases causing the
sample to be non-representative of the population of study).23,24
The phenomenon where irrelevant factors lead to misleading
good results is known as the Anna Karenina effect.12 Using
such mis-trained models in real world settings can produce un-
desirable consequences.24
TWO EXTENSIONS OF THE EV
IVevaluatesperformanceondata fromexactly thesameunderlying
population, whereas EV evaluates performance on data from
similar but not identical underlying populations. Different EVs
may each contribute data from different underlying populations
(e.g., different hospitals, different countries). EV on multiple data-
sets is important for revealing theheterogeneity inamodel’sperfor-
mance, and for fully appreciating the generalizability of a model.25
We propose two procedures that extend the EV. We call these
convergent and divergent validations. They have useful proper-
ties but require more work to execute26 (see Table 1 and Figure 2
for an overview). For in-depth details on implementations and4 PATTER 1, November 13, 2020outcomes of convergent and divergent validations, please refer
to, e.g., recent publications of Goh and Wong.6,14
There are three key benefits associated with convergent and
divergent validations: (1) convergent validation helps us identify
better features, leading to better domain-relevant models; (2)
divergent validation helps us eliminate domain-irrelevant models
because they cannot pass all datasets; and (3) divergent valida-
tion helps us identify good EV datasets. These key points are
elaborated below.
In convergent validation, you evaluate the information value of
multiple feature sets inferred from n datasets, use these to train n
models, and then challenge these n models against one valida-
tion data. Convergent validation is not a universally adopted
procedure (i.e., it is not a mature or regular practice, and not
introduced formally to the machine learning field; but it has
good potential application.) We propose the idea for convergent
validation based on the gene signature profiling work of Venet
et al.,15 where they compared the ability of different breast can-
cer gene signatures (here, these correspond to feature sets) in-
ferred from different studies against one single large high-quality
breast cancer dataset, the NKI.27 Venet et al.’s main purpose
was to demonstrate that each of the published gene signatures
performed poorly in prediction relative to randomly generated
signatures. However, the results can also be taken to mean
that each of the signatures has a chance to capture an aspect
of what is domain relevant. Thus, some signatures have higher
information value than others, whereas some had little informa-
tion value and could not predict the sample classes in the NKI
at all. Formally, each time a model is trained on one signature
and validated against the NKI counts as one independent valida-
tion of that signature. By considering the varied outcomes of
each of these independent validations, we may isolate strongly
performing signatures from weakly performing ones. In addition,
we can identify various levels of commonalities among the most
highly performing signatures. This allowed us to isolate a
strongly predictive 80-gene breast cancer signature that is
essentially inferred from the best performing signatures.6,14 We
call this signature the super proliferation set (SPS). Members of
this feature set are strongly correlated with breast cancer sur-
vival: inclusion of a small number of SPS genes is enough to
turn a non-useful signature into a strong predictor and, also,
the stronger a published signature the higher its overlap with
SPS genes.6,14 These observations suggest that the expression
changes of SPS genes are key events in breast cancer survival.
In this case study, the feature set garnered from convergent vali-
dation has high information value. The procedure is therefore
useful for isolating more meaningful explanations in the feature
sets, and therefore achieving better interpretability.
In divergent validation, the goal is to understand if a feature set
is truly generalizable. The approach involves using a feature set
to train a model and then challenging the model repeatedly
acrossmultiple validation datasets. Divergent validation is useful
for demonstrating that a feature set is universally applicable, and
that an initially observed good performance is not due to chance.
For example, when SPSwas benchmarked across seven new in-
dependent datasets, SPS was able to correctly predict the class
labels in all seven of these datasets, suggesting that the feature
set is domain relevant.6,14 This also suggests that (at least in the
context of breast cancer survival), there appears to be
Figure 2. Two Extensions of the EV:
Convergent and Divergent
Convergent validation uses multiple features sets to
train multiple models. Each model is, in turn,
benchmarked on a gold standard validation data-
set. Divergent validation uses a single feature set to
train one model followed by repeated challenging
with multiple datasets.
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test sets. This makes the point that, if one were satisfied that one
got a good signature because it worked in one hospital despite
failing in others, one would not have identified better and more
universal signatures (in the best case) or one would have ended
up with a random misleading signature that would likely fail next
week (in the worst case).
TECHNICAL CONSIDERATIONS FOR DEPLOYING EV
In this section, we cover four additional technical considerations
in deploying EV: (1) generating statistical rigor, (2) considerations
for acquiring ‘‘valid’’ external data, (3) how much data are
enough, and finally (4) what to do or how to think should the mul-
tiple external data exhibit controversial or contradictory results.
Generating Statistical Rigor
Complementing the above setup, we can make convergent and
divergent validations even more meaningful by combining the
observed accuracies with empirical and theoretical null distribu-
tions as reference points, using the example of Venet et al., in
which they compared the predictive performance of each re-
ported signature against randomly generated signatures of the
same size.15 The accuracies of these randomly generated signa-
tures constitute an empirical null distribution. This empirical null
distribution allows us to understand the information value of a
signature, as follows: suppose a validation accuracy of 90%
was observed for a model, which is a signature in this example,
it is useful to know whether this 90% is meaningful (Figure 3).
One way to proxy meaning is to assign a measure of significance
to the observed accuracy by checking the number of times a
randomly generated signature performs on par or better.28 Sup-
pose only 1 case out of 1,000 random cases equals or exceeds
90%, then the significance value—i.e., the p value—can be rep-
resented as a proportion, 1/1,000 or 0.001. This means that the
observed accuracy of 90% produced by this feature set is not
substitutable by noise. Alternatively, suppose in 900 out of
1,000 cases randomized feature sets perform better. Then, the
significance value is 900/1,000, or 0.90. This can mean twothings: the feature set on hand is substitut-
able by noise (and thus has no meaning) or
all measured features are essentially class-
correlated. Including the significance value
allows better evaluation of convergent vali-
dation by identifying which feature sets are
more likely to be meaningful.
In divergent validation, a similar tactic
can be used as well. Say, a given feature
set of size 80 is benchmarked across n vali-dation datasets, then 1,000 random feature sets of the same size
are generated and tested across each of these n validation data-
sets. For each of these 1,000 random feature sets, we count the
number of datasets for which it is able to correctly assign the class
labels. This forms an empirical null distribution of the number of
datasets that a random feature set can perform well on. Then
the number of datasets the given feature set performs well on is
compared against this empirical null distribution. If a significant
fraction, say 5%, of the 1,000 random feature sets perform well
on an equal or greater number of datasets than the given feature
set, the given feature set is likely substitutable by noise; otherwise,
the given feature set is likely not substitutable by noise.
Considerations for Acquiring Valid External Data
It is difficult to establish a priori, based on just the data descrip-
tions, to ascertain if external data are valid. One post-hoc pro-
cedure, as discussed later, is to perform divergent validation
and check if any of the external data exhibit unusual behaviors.
When training a model, training and EV data should be inde-
pendently derived. However, just because the training and test
data are independently derived does not mean that they make
a good training-validation pair. Suppose for some reason the
training and validation data are extremely similar, this would
guarantee a good validation outcome, yet it informs little on
whether a model has been learned intelligently. Such data dop-
pelg€angers directly affect a model’s performance. For example,
Cao and Fullwood5 did a detailed evaluation of existing chro-
matin interaction prediction systems. The work reveals that the
performance of these systems has been overstated because of
problems in assessment methodologies when these systems
were reported. In particular, these systems were evaluated on
validation data that shared a high degree of similarity to training
data. While it is good that the problem was discovered, it is sur-
prising that eliminating or minimizing similarity between test and
training data is still not a universal practice for model evaluation.
This explanation—that the data involved in the training-valida-
tion pair were never checked properly to ensure they were truly
dissimilar—also brings in the question of how different do the
data need to be and how to check for this.PATTER 1, November 13, 2020 5
Figure 3. A Schematic on How to Interpret Observed Validation
Accuracies against a Backdrop of Null Accuracies Using p Values
We use four mock external validation (EV1–EV4) scenarios to showcase that
high accuracy does not necessarily mean low p values (highly significant
outcomes). The violin plots represent null accuracies generated by randomi-
zation while the diamond represents the observed accuracy. The p value (p) is
the proportion where random accuracies outperforms observed accuracy.
Here, EV1 has an observed accuracy of 90%, and this performance is only
matched by 1 out of 1,000 random cases. The p value (p) is thus 0.001 (1/1,000)
and therefore this feature set is likely meaningful (or high information value). In
a second scenario, EV2 has the same observed accuracy as EV1 but this
performance is matched by 900 cases out of 1,000 cases. EV2’s p is thus 0.90,
suggesting that this feature set does not have clear information value. High
observed accuracies are not always meaningful: EV3 and EV4 are similar to
EV1 and EV2 but with appreciably lower accuracies. The same analysis can
also be performed. Low accuracy therefore does not mean low informa-
tion value.
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component analysis, coupled with scatterplots, to see how the
instances are scattered in multi-dimensional space. If the
training and validation data points are extremely clustered
together, you may expect that the validation results will turn
out well. But this does not give us an intuitive or robust way to
avoid the doppelg€anger effect.
One practicewe have observed is to abandon the training-vali-
dation distinction altogether and mix the data to derive a larger
sample that is hopefully more domain representative, and to
test for performance stability instead.29 Alternatively, leveraging
on domain-relevant contexts may also work. For example, Cao
and Fullwood5 called for more comprehensive and rigorous
assessment strategies, based on the particular context of the
data being analyzed. In their case, to split training and test
data based on individual chromosomes (instead of considering
all chromosomes together), and to use different cell types to
generate gold standard training-validation pairs, thus establish-
ing better practices/standards in the domain.
It is non-trivial to propose universal measures to guarantee
valid EV data. We have to be careful to guard against data dop-
pelg€angers. It is also useful to perform multiple rounds of EVs6 PATTER 1, November 13, 2020(divergent validation) and to check for consistency. Should any
external data behave unusually, it is possible that these data
may have issues, and their validity should be called into
question.Determining Sufficient EVs
In our previous simulations with randomly generated feature sets
that are then tested against multiple external data, we find that
these meaningless feature sets can be used to construct models
that somehow work with some but not all external data (an illus-
tration of this is shown in Figure 4). This is expected because we
do not expect models constructed from meaningless feature
sets to generalize during a divergent validation. However, this
assumes that there are sufficient numbers of independent data-
sets for the divergent validation. In particular, if there are too few
independent datasets in the divergent validation, many models
constructed from meaningless feature sets may still perform
well on all of the independent datasets.
Thus, it is important to determine the number of independent
datasets needed in a divergent validation to keep models from
meaningless feature sets under control. Earlier, we mentioned
generating an empirical null distribution using random feature
sets on a given test data. This empirical null distribution can be
used to infer a bound on the number of independent datasets
needed. In particular, the fraction of random feature sets that
performs on a par or better than a given feature set on this test
data, i.e., the p value, is also the probability of a random feature
set performing well on a test data. Therefore, the probability of a
random feature set performing well on n independent test data is
pn. In other words, if we want no more than say 1% of random
feature sets to pass a divergent validation, i.e., pn < 0.01, there
should be n > 0.01/log(p) independent datasets. For example,
when half the random feature sets can perform well on a test
data, i.e., p = 0.5, n = 7 independent test data are needed to
keep random feature sets at bay. More generally, binomial distri-
bution is appropriate for constructing the expected behavior for
how models trained with random signatures perform in the
external divergent validation. Specifically, the probability that a
random feature set is able to do well on k independent external




pkð1 pÞnk , where n is the total number of external data-
sets and p is the probability that a random feature set is able to
do well in a dataset. Thus the number of random feature sets ex-
pected to performwell on k external dataset is given by prob(k; n,
p) *x, where x is the total number of random feature sets being
considered. In our breast cancer example, x = 1,000 random
feature sets were generated; about half of the random feature
sets was able to perform well on the NKI dataset, thus p = 0.5;
this means a random signature has a probability of pn to perform
well on n datasets; so n was set to 7 to keep pn < 1%.
As shown in both Figure 4 scenarios, using the binomial distri-
bution as a theoretical model (red bars), it is extremely difficult
models trained on random feature sets will work on all seven
external data. In the scenario below (Figure 4), we observe that
such random models seldom work on more than four EV data.
So, four external datasets may be sufficient where external
data are in short supply.
Figure 4. Divergent Validation Comparing
Published Signatures (Yellow), Expected
Theoretical Distribution Based on the
Binomial Distribution (Red), and Randomized
Signatures (Blue) across Seven Datasets
The y axis is a frequency count based on the x axis,
which represents the number of validation datasets
for which a signature is predictive on. Left illustrates
the situation where random signatures do not work
well in more than three datasets (although it was
later found that it was always the same three data-
sets that has this issue with random signatures).
Right is a repeat experiment using seven new
curated datasets with better outcome. The ran-
domized signatures are more evenly distributed
although their performance is appreciably lower
than purely random (based on the binomial distri-
bution). The fact that it is not always the same da-
tasets that are confounded with random signatures
means these curated datasets are more well suited
to serve as independent validation data.
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We may use the information encapsulated in divergent validation
(Figure 4) to determine issues in the validation datasets. In the first
example (Figure 4, left), across seven validationdata, an extremely
high blue peakwas observed at n = 3,meaning thatmost random-
ized feature sets work well on three external data. This deviates
from the expected binomial distribution and is suggestive that
the seven validation datasets may not be independent of each
other and may not be independent of the training data.
Indeed, a closer inspection revealed that it was often the same
three datasets contributing to the blue peak in Figure 4 (left).
These observations suggest that these validation datasets
consistently work with randommodels. Obviously, such external
data should be avoided.
We repeated the divergent validation experiment on a new set
of closely curated data (Figure 4, right). This time, the observed
performance (blue) is more even, although it still does not match
well with the theoretical binomial distribution (red)—suggesting
that our estimated value of the probability p is too high. At the
same time, it is noteworthy that themodels trained onmeaningful
feature sets worked on all external data (yellow).
These observations lead toward two critical insights: firstly, a
meaningful feature set should always work well with any valid
external dataset and must exceed the performance of random-
ized feature sets. Secondly, the application of random feature
sets (with zero information value) on divergent validation allows
identification of valid external data.
RELEVANCE OF EV TO NEW MACHINE LEARNING
DEVELOPMENTS
While convergent and divergent validations have useful proper-
ties, they are not panaceas—that is, they will not guarantee
that your classifiers aremeaningfully generalizable. For example,
when most features are correlated with the class labels, EVs will
do no better than traditional validation approaches. However,
you can detect this issue by adding statistical reference points
when conducting the EV (Figure 4).
There are also growing trends in the machine learning area
where data frommultiple sources are leveraged to learn a model
that has the potential to generalize well. For example, federated
learning (FL) is a machine learning setup where many devices,acting as nodes in a network, collaboratively train a model under
the coordination of a central server.30 This has parallels to
convergent validation where each classifier basically has access
to only part of the data. However, unlike convergent validation,
each node in FL forms part of a large single network-based clas-
sifier whose activities are coordinated centrally. Another key dif-
ference is control—in convergent validation, unwanted bias is
minimized by using a global curated training data, whereas in
FL this does not happen (FL is a technological solution focusing
on secure data collection). FL and convergent validation also
may experience similar issues to local data heterogeneity,
such that each node or classifier may have some bias with
respect to the true underlying population.
In FL, local models can also be generated instead of a sin-
gle global model. Here, we speculate an evolution from FL to
federated testing, so that data residing in other nodes are
used as validation data for divergent validation. This is a
tantalizingly applicable scenario for personalized modeling.
In this context, there is no global model. Instead, a separate
new model is created for all new data (with unknown outcome)
using the extended local repository of data until that moment
in time. The new model can be dispatched—as a black box
with a ‘‘good behavior promise’’—to federated nodes for
divergent validation. In this way, only a summary of the
black box’s performance on a node is passed back to origi-
nating node, and no data from one node is passed to another
node.
OTHER PERFORMANCE MEASURES
Althoughwemade our point for EV using the class-prediction ac-
curacy as the primary performancemeasure, this does not mean
that the class-prediction accuracy is a truly useful or objective
measure. In fact, it is often argued that accuracy is an uninterest-
ing or limited measure in most applications as it is influenced by
class imbalances and other instability issues.4We do not dispute
that. But simply state that it is convenient for use with valid stra-
tegies. Moreover, for test sets, class imbalance in itself is not the
issue); the issue is class proportion being too different from real
life, affecting interpretation of accuracy. If we know what the real
life proportion is, we can report a calibrated accuracy that can be
more correctly interpreted.4,31PATTER 1, November 13, 2020 7
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recall-measure, can objectively prove generalizability where
the accuracy cannot, we remain skeptical. There have also
been some misleading discussions about Cohen’s kappa be-
ing resilient against class imbalance issues (https://
thedatascientist.com/performance-measures-cohens-kappa-
statistic/). Cohen’s kappa is a proportion indicating whether a
learned model’s performance is better than that of a randomly
guessing model (which guesses according to the frequency of
each class). Cohen’s kappa is also sensitive to class imbal-
ance; if class proportion changes, Cohen’s kappa can also
change dramatically. Say test set 1 has a 20:80 split of posi-
tives versus negatives, and sensitivity = specificity = 80%;
then kappa = 0.49. Say test set 2 has a 50:50 split and sensi-
tivity = specificity = 80%; then kappa = 0.60. The kappa value
does indicate that the performance on test set 2 may be due
less to chance than that on test set 1; but it is misleading to
think—purely on the basis of kappa—that the performance
on test set 2 is higher than on test set 1, as the sensitivity
and specificity are actually identical on both test sets.
Sensitivity and specificity together (and thus ROC), since
they are not affected by class imbalance, are more robust
than kappa. It is in fact possible to compute a confidence inter-
val (CI) for both sensitivity and specificity, to interpret against
chance, although these are seldom computed in the machine
learning community. For example, the CI of sensitivity and
specificity can be computed as a simple asymptotic CI, at least
for datasets that are not too small.32 These perspectives can
help provide some assurance quality. Although we have not
used these ourselves, we think that they may be useful for eval-
uating EV performance.
CONCLUSIONS AND FUTURE DIRECTIONS
Achieving domain-relevant models in machine learning is chal-
lenging but necessary for achieving good explainability and
generalizability. Wemay admit better quality models by perform-
ing EV better. It is not an error-free process: a good performance
in a single independent validation does not guarantee that the
model generalizes. EV procedure can be influenced by factors,
such as the coverage of the feature set and its correlation with
data classes, the presence of technical bias such as batch ef-
fects, and whether there is unknown data leakage between the
training and validation data.
Designing robust EV technique is highly useful. Because the
procedures constitute a core part of machine learning model
evaluation, our proposed extensions of the EV are also valid
beyond the health and bioscience domains. Given that many da-
tasets and feature sets exist for many modeling problems, it is
feasible to perform both convergent and divergent validation
methods, as extensions of the traditional independent validation.
These two procedural extensions are synergistic, allowing us to
take advantage of existing data to develop more robust models:
Convergent validation can help to identify domain-relevant
feature sets, which provide high explainability, and therefore bet-
ter interpretable models. But to know which of these models are
indeed more likely correct, a single independent validation is
insufficient. Divergent validation allows to rigorously test for
generalizability. It also allows to detect confounding issues be-8 PATTER 1, November 13, 2020tween the training and validation data, as well as between
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